Encapsulated Bifidobacteria reduced bacterial translocation in rats following hemorrhagic shock and resuscitation

Nutrition

Volumn 23, Issue 10, 2007, Pages 754-761

  Ruan, Xiangcai ^a,b   Shi, Hanping ^a   Xia, Gengfeng ^c   Xiao, Ying ^a   Dong, Jiaxi ^c   Ming, Feiping ^c   Wang, Shenming ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^c Guangzhou Design Institute   (China)

Author keywords

Bacterial translocation; Bifidobacterium; Hemorrhagic shock; Microencapsulation; Microflora

Indexed keywords

ENDOTOXIN; PHOSPHATE BUFFERED SALINE; PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL TRANSLOCATION; BIFIDOBACTERIUM; CECUM; COLONY FORMING UNIT; COMPARATIVE STUDY; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENCAPSULATION; HEMORRHAGIC SHOCK; ILEUM; INCIDENCE; INTESTINE FLORA; INTESTINE INJURY; INTESTINE VILLUS; LAPAROTOMY; MALE; MESENTERY LYMPH NODE; MICROBIOLOGY; MICROENCAPSULATION; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; RAT; RESUSCITATION; SEPSIS;

ANIMALS; BACTERIAL TRANSLOCATION; BIFIDOBACTERIUM; CECUM; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DRUG COMPOUNDING; ENDOTOXINS; HUMANS; ILEUM; INTESTINAL MUCOSA; MALE; PROBIOTICS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; SHOCK, HEMORRHAGIC;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; RATTUS;

EID: 34548636189     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2007.07.002     Document Type: Article

References (38)

1. Deitch E.A., Bridges W., Baker J., Ma J.W., Ma L., Grisham M.B., et al. Hemorrhagic shock-induced bacterial translocation is reduced by xanthine oxidase inhibition or inactivation. Surgery 104 (1988) 191-198
2. Deitch E.A. Bacterial translocation or lymphatic drainage of toxic products from the gut: what is important in human beings?. Surgery 131 (2002) 241-244
3. Gonzalez E.A., Kozar R.A., Suliburk J.W., Weisbrodt N.W., Mercer D.W., and Moore F.A. Conventional dose hypertonic saline provides optimal gut protection and limits remote organ injury after gut ischemia reperfusion. J Trauma 61 (2006) 66-73
4. Moore F.A., McKinley B.A., and Moore E.E. The next generation in shock resuscitation. Lancet 363 (2004) 1988-1996
5. Moore F.A., Moore E.E., Poggetti R.S., and Read R.A. Postinjury shock and early bacteremia. A lethal combination. Arch Surg 127 (1992) 893-897
6. Westerbeek E.A., van den Berg A., Lafeber H.N., Knol J., Fetter W.P., and van Elburg R.M. The intestinal bacterial colonisation in preterm infants: a review of the literature. Clin Nutr 25 (2006) 361-368
7. Yang R., Han X., Uchiyama T., Watkins S.K., Yaguchi A., Delude R.L., and Fink M.P. IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am J Physiol Gastrointest Liver Physiol 285 (2003) G621-G629
8. MacFie J. Current status of bacterial translocation as a cause of surgical sepsis. Br Med Bull 71 (2004) 1-11
9. Ishibashi N., and Yamazaki S. Probiotics and safety. Am J Clin Nutr 73 (2001) 465S-70.
10. Heyman M., and Menard S. Probiotic microorganisms: how they affect intestinal pathophysiology. Cell Mol Life Sci 59 (2002) 1151-1165
11. Fedorak R.N., and Madsen K.L. Probiotics and prebiotics in gastrointestinal disorders. Curr Opin Gastroenterol 20 (2004) 146-155
12. Elmer G.W., Surawicz C.M., and McFarland L.V. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 275 (1996) 870-876
13. Gionchetti P., Rizzello F., Helwig U., Venturi A., Lammers K.M., Brigidi P., et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124 (2003) 1202-1209
14. Johnson-Henry K.C., Mitchell D.J., Avitzur Y., Galindo-Mata E., Jones N.L., and Sherman P.M. Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice. Dig Dis Sci 49 (2004) 1095-1102
15. Zareie M., Johnson-Henry K., Jury J., Yang P.C., Ngan B.Y., McKay D.M., et al. Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 55 (2006) 1553-1560
16. Dinoto A., Suksomcheep A., Ishizuka S., Kimura H., Hanada S., Kamagata Y., et al. Modulation of rat cecal microbiota by administration of raffinose and encapsulated Bifidobacterium breve. Appl Environ Microbiol 72 (2006) 784-792
17. Park J.H., Um J.I., Lee B.J., Goh J.S., Park S.Y., Kim W.S., and Kim P.H. Encapsulated Bifidobacterium bifidum potentiates intestinal IgA production. Cell Immunol 219 (2002) 22-27
18. Shi H.P., Deitch E.A., Da Xu Z., Lu Q., and Hauser C.J. Hypertonic saline improves intestinal mucosa barrier function and lung injury after trauma-hemorrhagic shock. Shock 17 (2002) 496-501
19. Isolauri E., Kirjavainen P.V., and Salminen S. Probiotics. A role in the treatment of intestinal infection and inflammation?. Gut 50 suppl 3 (2002) III54-III59
20. Watkinson P.J., Barber V.S., Dark P., and Young J.D. The use of pre- pro- and synbiotics in adult intensive care unit patients: systematic review. Clin Nutr 26 (2007) 182-192
21. Luyer M.D., Buurman W.A., Hadfoune M., Speelmans G., Knol J., Jacobs J.A., et al. Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock. Infect Immun 73 (2005) 3686-3692
22. Katouli M., Bark T., Ljungqvist O., Svenberg T., and Mollby R. Composition and diversity of intestinal coliform flora influence bacterial translocation in rats after hemorrhagic stress. Infect Immun 62 (1994) 4768-4774
23. Wang Z., Xiao G., Yao Y., Guo S., Lu K., and Sheng Z. The role of bifidobacteria in gut barrier function after thermal injury in rats. J Trauma 61 (2006) 650-657
24. Gibson G.R., and Wang X. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 77 (1994) 412-420
25. Llovet J.M., Bartoli R., Planas R., Vinado B., Perez J., Cabre E., et al. Selective intestinal decontamination with norfloxacin reduces bacterial translocation in ascitic cirrhotic rats exposed to hemorrhagic shock. Hepatology 23 (1996) 781-787
26. Weber E.L., Rhoden E.L., Morais E.N., Zettler C.G., de Oliveira Alberto B., Diesel C., et al. The role of antibiotic prophylaxis with sodium ceftriaxone to prevent bacterial translocation associated with hypovolemic shock: an experimental study in rats. J Invest Surg 17 (2004) 203-209
27. Woodcock N.P., Mahadeva S., Sudworth P., Johnstone D., and MacFie J. An investigation into the sensitivities of translocating bacteria to a prophylactic antibiotic regimen. Ann R Coll Surg Engl 84 (2002) 422-425
28. Fujiwara S., Hashiba H., Hirota T., and Forstner J.F. Proteinaceous factor(s) in culture supernatant fluids of bifidobacteria which prevents the binding of enterotoxigenic Escherichia coli to gangliotetraosylceramide. Appl Environ Microbiol 63 (1997) 506-512
29. Lievin V., Peiffer I., Hudault S., Rochat F., Brassart D., Neeser J.R., and Servin A.L. Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut 47 (2000) 646-652
30. Schiffrin E.J., Rochat F., Link-Amster H., Aeschlimann J.M., and Donnet-Hughes A. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 78 (1995) 491-497
31. Jiang J., Bahrami S., Leichtfried G., Redl H., Ohlinger W., and Schlag G. Kinetics of endotoxin and tumor necrosis factor appearance in portal and systemic circulation after hemorrhagic shock in rats. Ann Surg 221 (1995) 100-106
32. van Deventer S.J., ten Cate J.W., and Tytgat G.N. Intestinal endotoxemia. Clinical significance. Gastroenterology 94 (1988) 825-831
33. Park S.Y., Ji G.E., Ko Y.T., Jung H.K., Ustunol Z., and Pestka J.J. Potentiation of hydrogen peroxide, nitric oxide, and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of Bifidobacterium. Int J Food Microbiol 46 (1999) 231-241
34. Guarner F., and Malagelada J.R. Gut flora in health and disease. Lancet 361 (2003) 512-519
35. Griffiths E.A., Duffy L.C., Schanbacher F.L., Qiao H., Dryja D., Leavens A., et al. In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice. Dig Dis Sci 49 (2004) 579-589
36. El-Nezami H., Polychronaki N., Salminen S., and Mykkanen H. Binding rather than metabolism may explain the interaction of two food-grade Lactobacillus strains with zearalenone and its derivative (')alpha-earalenol. Appl Environ Microbiol 68 (2002) 3545-3549
37. Kwok K.K., and Burgess D.J. A novel method for determination of sterility of microcapsules and measurement of viability of encapsulated organisms. Pharm Res 9 (1992) 410-413
38. Yamazaki S., Machii K., Tsuyuki S., Momose H., Kawashima T., and Ueda K. Immunological responses to monoassociated Bifidobacterium longum and their relation to prevention of bacterial invasion. Immunology 56 (1985) 43-50